XORTX Therapeutics Total Liabilities

XORTX Therapeutics (XRTX) currently reports a total liabilities of $860K as of March 2026. That compares with $760K in the prior-year period — up 14.1% year over year. Use the charts on this page to explore XORTX Therapeutics's total liabilities history and peer comparisons.

XORTX Therapeutics's total liabilities increased from $760K to $860K — a 14.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XORTX Therapeutics reported $860K in total liabilities as of March 2026. That compares with $760K in the prior-year period — up 14.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $860K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XORTX Therapeutics, and consider following XRTX for alerts when major investors trade the stock.

XORTX Therapeutics is classified in the Materials sector. On total liabilities, it currently shows $860K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing XRTX with unrelated industries.